Clever Leaves Holdings, Inc. (CLVR)
| Market Cap | 225.64M |
| Revenue (ttm) | 12.12M |
| Net Income (ttm) | -36.68M |
| Shares Out | 24.93M |
| EPS (ttm) | -4.34 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 14 |
| Last Price | $8.63 |
| Previous Close | $8.45 |
| Change ($) | 0.18 |
| Change (%) | 2.13% |
| Day's Open | 8.55 |
| Day's Range | 8.46 - 8.82 |
| Day's Volume | 129,670 |
| 52-Week Range | 8.02 - 19.46 |
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator, or MNO, and licensed producer of pharm...
These up-and-coming cannabis companies may be small, but investing in them could lead to significant returns.
Benzinga's Cannabis Insider is a live daily show for cannabis investors. On Tuesday's show, hosts Patrick Lane and Javier Hasse discussed Global and Colombian Cannabis Industry with Kyle Detwiler, CEO...
Multi-national cannabis operator Clever Leaves Holdings Inc. (NASDAQ:CLVR) reported Tuesday afternoon its fourth-quarter revenue increased 28% year-over-year to $3.3 million. Full-year 2020 revenue amou...
- Q4 and Full Year 2020 Revenue Increases 28% and 55%, Respectively -
NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutic...
Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-...
Clever Leaves' quota represents 50% of the total quota for Colombia and approximately 18% of the world's legal production quota of medical cannabis Clever Leaves' quota represents 50% of the total quota...
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutica...
Key Milestone Accomplished Through Partnership Between Clever Leaves, TruSource, and LooperGroup Key Milestone Accomplished Through Partnership Between Clever Leaves, TruSource, and LooperGroup
Clever Leaves is a cannabis company that has one of the lowest costs of production in an industry that is rapidly commoditizing. Since its SPAC, Clever Leaves has the best financial metrics in the indus...
SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient funding process....
SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient funding process....
Clever Leaves to Receive US$11.4 Million Over Three-year Deal Clever Leaves to Receive US$11.4 Million Over Three-year Deal
It's no secret that small caps offer the potential for greater returns for those who can recognize companies trading at discounts to their intrinsic values. But many small-caps are unknown, leaving inve...
NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade...
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutica...
CLVR stock will start trading on the Nasdaq today after Clever Leaves completed its SPAC merger with Schultze Special Purpose Acquisition. The post CLVR Stock: 12 Things to Know as Cannabis Play Clever ...
Common Shares and Warrants of the Combined Company to Begin Trading on Nasdaq Under Symbols CLVR and CLVRW on Friday, December 18, 2020 Common Shares and Warrants of the Combined Company to Begin Tradin...
SPACs have been one of the hottest investment stories of 2020. The blank check, reverse merger vehicles have taken numerous private companies — as well as former public companies — public on major excha...
The improving regulatory landscape for marijuana stocks could usher in a boom, particularly for companies focused on the U.S. market. The post 7 Marijuana Stocks Hoping 2021 Brings Federal Legalization ...
Former U.S. Senate Majority Leader, Tom Daschle Will Also Discuss Cannabis Regulation and Legislation Former U.S. Senate Majority Leader, Tom Daschle Will Also Discuss Cannabis Regulation and Legislation
Companies to Host Joint Investor Webinar and Q&A Session Today at 11:00 AM ET Companies to Host Joint Investor Webinar and Q&A Session Today at 11:00 AM ET
RYE BROOK, N.Y., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (Nasdaq: SAMA, SAMAW and SAMAU) (the “Company”) today announced that it intends to convene and then adjou...
RYE BROOK, N.Y., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”) today an...
Electrameccanica Vehicles’ flagship vehicle, the SOLO, is interesting. Yet SOLO stock wouldn’t be my first choice for $170 million.
Presentation and Q&A Session Scheduled for Thursday, September 10 at 11:00 AM EDT Presentation and Q&A Session Scheduled for Thursday, September 10 at 11:00 AM EDT
These SPACs have already found companies to complete reverse mergers with. Look for the SPAC stocks to double or even triple in the next year.
RYE BROOK, N.Y., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) announced today that Clever Leaves Holdings Inc. (“Holdco”) file...
Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA) made a notable move on Monday.
About CLVR
Clever Leaves Holdings Inc. cultivates, extracts, manufactures, and commercializes pharmaceutical-grade cannabinoid products in Colombia, Portugal, Germany, the United States, and Canada. The company operates through two segments, Cannabinoid and Non-Cannabinoid. It also engages in the formulating, manufacturing, marketing, distributing, and selling of homeopathic and other natural remedies, wellness products, detoxification products, nutraceuticals, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | Founded 2016 |
| Stock Exchange NASDAQ | Ticker Symbol CLVR |
Financial Performance
In 2020, Clever Leaves's revenue was $12.12 million, an increase of 54.67% compared to the previous year's $7.83 million. Losses were -$36.68 million, -7.22% less than in 2019.